These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26539792)

  • 1. Statistical Analysis of a Method to Predict Drug-Polymer Miscibility.
    Knopp MM; Olesen NE; Huang Y; Holm R; Rades T
    J Pharm Sci; 2016 Jan; 105(1):362-7. PubMed ID: 26539792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ; Shamblin SL; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling as a predictive tool for the development of solid dispersions.
    Maniruzzaman M; Pang J; Morgan DJ; Douroumis D
    Mol Pharm; 2015 Apr; 12(4):1040-9. PubMed ID: 25734898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.
    Marsac PJ; Li T; Taylor LS
    Pharm Res; 2009 Jan; 26(1):139-51. PubMed ID: 18779927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems.
    Meng F; Dave V; Chauhan H
    Eur J Pharm Sci; 2015 Sep; 77():106-11. PubMed ID: 26006307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.
    Thakore SD; Akhtar J; Jain R; Paudel A; Bansal AK
    Mol Pharm; 2021 Aug; 18(8):2835-2866. PubMed ID: 34041914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
    Qian F; Huang J; Hussain MA
    J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Thermal Imaging Method for Rapid Screening of Drug-Polymer Miscibility for Solid Dispersion Based Formulation Development.
    Alhijjaj M; Belton P; Fábián L; Wellner N; Reading M; Qi S
    Mol Pharm; 2018 Dec; 15(12):5625-5636. PubMed ID: 30372612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions.
    Ivanisevic I; Bates S; Chen P
    J Pharm Sci; 2009 Sep; 98(9):3373-86. PubMed ID: 19283767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
    Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
    Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Study of Different Methods for the Prediction of Drug-Polymer Solubility.
    Knopp MM; Tajber L; Tian Y; Olesen NE; Jones DS; Kozyra A; Löbmann K; Paluch K; Brennan CM; Holm R; Healy AM; Andrews GP; Rades T
    Mol Pharm; 2015 Sep; 12(9):3408-19. PubMed ID: 26214347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method to predict the equilibrium solubility of drugs in solid polymers near room temperature using thermal analysis.
    Bellantone RA; Patel P; Sandhu H; Choi DS; Singhal D; Chokshi H; Malick AW; Shah N
    J Pharm Sci; 2012 Dec; 101(12):4549-58. PubMed ID: 22987330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Solubility/Miscibility in Amorphous Dispersions: It Is Time to Move Beyond Regular Solution Theories.
    Anderson BD
    J Pharm Sci; 2018 Jan; 107(1):24-33. PubMed ID: 29031973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
    J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Taylor LS
    Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Promising New Method to Estimate Drug-Polymer Solubility at Room Temperature.
    Knopp MM; Gannon N; Porsch I; Rask MB; Olesen NE; Langguth P; Holm R; Rades T
    J Pharm Sci; 2016 Sep; 105(9):2621-2624. PubMed ID: 27012222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.